
|Articles|January 1, 2005
What's new in PMS?
PMS has been a legitimate diagnosis for several decades, but there are no FDA-approved therapies for it. Off-label use of medications that are FDA-approved for PMDD is common in clinical practice. For patients taking daily SSRIs for anxiety or mood symptoms, premenstrual dose adjustment offers a novel management strategy.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA working with manufacturers to increase access to estradiol transdermal patches
2
Positively Pregnant tool helps patients time home pregnancy testing
3
Amber Watters, MD, on anesthesia in external cephalic version for breech presentation
4
ACOG's 2026-27 respiratory vaccine guidance, estradiol patch supply update, and more
5






